BioVie Inc. Form CORRESP: Company correspondence with SEC staff
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-08-04: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2025-08-04: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2025-07-24: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2025-07-24: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-08-04 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-08-04 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-24 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-24 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-22 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-22 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2024-11-29 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2024-03-15 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-08-24 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-04-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-04-06 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2021-02-01 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-09-16 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-09-16 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-11-05 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-11-05 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-10-04 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-08-12 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-08-08 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-08-08 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-07-09 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-06-28 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-03-28 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2016-06-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2016-05-19 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2013-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |